Skip to content
In English |
En español
National Cancer Institute
at the National Institutes of Health
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
Email This Document
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
LiveHelp online chat
Popular Resources
Help Using the NCI Clinical Trials Search Form
Learn About Clinical Trials
About NCI's List of Cancer Clinical Trials
NCI Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-14 of 14 for your search:
Drug:
retinol
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III Chemotherapy with Busulfan with or without Vitamin A for Chronic Myelogenous Leukemia (Summary Last Modified 07/97)
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
SWOG-7984
2.
Phase III Postoperative Therapy with Vitamin-A vs No Further Treatment for Poor-Prognosis Stage I Melanoma (Summary Last Modified 07/97)
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
SWOG-8049
3.
Phase III Surgery Followed by No Further Therapy vs Vitamin A vs ACT-D/DTIC for Recurrent Malignant Melanoma (Summary last modified 06/97)
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
SWOG-8111
4.
Phase III Randomized Study of Immunotherapy with BCG with vs without Vitamin A for Resected, Poor-Prognosis Malignant Melanoma
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
UARIZ-MEL-1
5.
Phase III Randomized Comparison of the Influence of Chemoprevention with Vitamin A and/or N-Acetylcysteine vs No Treatment on Development and Detection of Second Primary Cancers in Patients Curatively Treated for Laryngeal, Oral Cavity, and Nonsmall Cell Lung Carcinoma
Phase:
Phase III
Type:
Prevention
Status:
Closed
Age:
75 and under
Sponsor:
Protocol IDs:
EORTC-08871
, EORTC-24871
6.
Study of the Effect of Nutritional Intervention on Esophageal Cancer in Linxian, People's Republic of China (Summary Last Modified 10/88)
Phase:
Phase III
Type:
Prevention
Status:
Completed
Age:
40 to 69
Sponsor:
Protocol IDs:
DCPC-CPSB-11204
7.
Phase III Study of Isotretinoin vs Vitamin A vs Placebo for the Prevention of Skin Cancer in Patients with a History of Basal and Squamous Cell Carcinoma of the Skin (Summary Last Modified 10/89)
Phase:
Phase III
Type:
Prevention
Status:
Closed
Age:
21 to less than 85
Sponsor:
Protocol IDs:
UARIZ-P89-0002
, NCI-P89-0002
8.
Phase III Randomized, Double-Blind Study of Multiple Vitamins at the Recommended Daily Allowance (RDA) vs Multiple Vitamins at the RDA plus High-Dose Vitamins A, B6, C, and E in Patients with Transitional Cell Carcinoma of the Bladder (Summary Last Modified 06/91)
Phase:
Phase III
Type:
Supportive care
Status:
Closed
Age:
any age
Sponsor:
Protocol IDs:
WVU-11715
, NCI-V91-0025
9.
Phase III Randomized Chemoprevention Study of Long-Term, Low-Dose Isotretinoin vs Vitamin A in Patients with Premalignant Lesions of the Oral Cavity (Summary Last Modified 06/97)
Phase:
Phase III
Type:
Prevention
Status:
Closed
Age:
18 and over
Sponsor:
Other
Protocol IDs:
MDA-DM-90096
, NCI-V93-0310
10.
Phase I/II Study of Chemopreventive Agents for the Prevention of Skin Cancer (Summary Last Modified 04/1999)
Phase:
Phase II, Phase I
Type:
Prevention
Status:
Completed
Age:
50-84
Sponsor:
NCI
Protocol IDs:
MDA-ID-95184
, NCI-P97-0099
11.
Phase II Chemotherapy with Nafoxidine vs Hormone Therapy with Tamoxifen for Disseminated Breast Cancer
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
WSU-C-25677
12.
Safety of Antioxidants During GYN Cancer Care
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
No age specified
Sponsor:
Other
Protocol IDs:
10006
, NCT00284427
13.
Long-Term Monitoring of Potential Side Effects and Adherence in Subjects at High Risk for Lung Cancer Enrolled in Two Chemoprevention Studies with Beta Carotene and Retinol: Vanguard Study (Summary Last Modified 11/92)
Phase:
No phase specified
Type:
Prevention
Status:
Closed
Age:
45 to 74
Sponsor:
Protocol IDs:
FHCRC-VANGUARD
, NCI-P92-0028
14.
Randomized, Placebo-Controlled Beta Carotene and Retinol Efficacy Trial (CARET) for Chemoprevention of Lung Cancer in High-Risk Populations
Phase:
No phase specified
Type:
Prevention
Status:
Closed
Age:
45 to 69
Sponsor:
Protocol IDs:
FHCRC-CARET
, NCI-P92-0029
Select All on Page
Help with Results
We Can Answer Your Questions
1-800-4-CANCER
LiveHelp Online Chat
NCI Home
Contact Us
Policies
Accessibility
Viewing Files
FOIA
Site Help
Site Map
Other Versions of this Site:
Mobile
|
Español
Follow Us:
Twitter
YouTube
Facebook
RSS
NIH…Turning Discovery Into Health
®